NCT00733460View on ClinicalTrials.gov

A Phase I Study to Evaluate BFPET as a Potential Myocardial Perfusion Imaging(MPI) Agent for PET

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Coronary Artery Disease

Interventions

DRUG

BFPET

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

Sponsors

Lead Sponsor

Fluoropharma, Inc.

All Listed Sponsors

lead

Fluoropharma, Inc.

INDUSTRY